These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27373931)

  • 1. Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Chong HT; Yang GN; Sidhu S; Ibbetson J; Kopecki Z; Cowin AJ
    Br J Dermatol; 2017 Mar; 176(3):705-712. PubMed ID: 27373931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
    Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
    Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
    Chamcheu JC; Siddiqui IA; Adhami VM; Esnault S; Bharali DJ; Babatunde AS; Adame S; Massey RJ; Wood GS; Longley BJ; Mousa SA; Mukhtar H
    Int J Nanomedicine; 2018; 13():4189-4206. PubMed ID: 30057446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
    Vasseur P; Pohin M; Jégou JF; Favot L; Venisse N; Mcheik J; Morel F; Lecron JC; Silvain C
    Br J Dermatol; 2018 Jul; 179(1):101-109. PubMed ID: 29150843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease.
    Kopecki Z; Stevens NE; Chong HT; Yang GN; Cowin AJ
    Front Immunol; 2018; 9():1833. PubMed ID: 30147695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3.
    Adams DH; Ruzehaji N; Strudwick XL; Greenwood JE; Campbell HD; Arkell R; Cowin AJ
    Br J Dermatol; 2009 Aug; 161(2):326-36. PubMed ID: 19519830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency.
    Scholz T; Weigert A; Brüne B; Sadik CD; Böhm B; Burkhardt H
    PLoS One; 2017; 12(8):e0182646. PubMed ID: 28777803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flightless I is a key regulator of the fibroproliferative process in hypertrophic scarring and a target for a novel antiscarring therapy.
    Cameron AM; Turner CT; Adams DH; Jackson JE; Melville E; Arkell RM; Anderson PJ; Cowin AJ
    Br J Dermatol; 2016 Apr; 174(4):786-94. PubMed ID: 26521845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
    Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
    Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
    Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
    Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold atmospheric plasma ameliorates imiquimod-induced psoriasiform dermatitis in mice by mediating antiproliferative effects.
    Gan L; Duan J; Zhang S; Liu X; Poorun D; Liu X; Lu X; Duan X; Liu D; Chen H
    Free Radic Res; 2019 Mar; 53(3):269-280. PubMed ID: 30663913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice.
    Zhou Y; Han D; Follansbee T; Wu X; Yu S; Wang B; Shi Z; Domocos DT; Carstens M; Carstens E; Hwang ST
    J Cell Mol Med; 2019 Jul; 23(7):4819-4828. PubMed ID: 31111624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
    Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
    Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice.
    Liang L; Fei WM; Zhao ZQ; Hao YY; Zhang C; Cui Y; Guo XD
    Eur J Pharm Biopharm; 2021 Jul; 164():20-27. PubMed ID: 33895291
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bezdek S; Leng L; Busch H; Mousavi S; Rades D; Dahlke M; Zillikens D; Bucala R; Sadik CD
    Front Immunol; 2018; 9():2262. PubMed ID: 30333830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin.
    Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita.
    Kopecki Z; Ruzehaji N; Turner C; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ
    J Invest Dermatol; 2013 Apr; 133(4):1008-16. PubMed ID: 23223144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.